Paulo R. Machado
Possui graduação em Medicina pela Universidade Federal da Bahia (1983), mestrado em Medicina pela Universidade Federal da Bahia (1997) e doutorado em Medicina pela Universidade Federal da Bahia (2003). Realizou pós-graduação em Imunodermatologia no INSERM U209 em Lyon, de 1990 a 1991. Obteve Master of Science pela Cornell University em 2014. Atualmente é Coordenador e Pesquisador Associado do Serviço de Imunologia do Hospital Universitário Prof. Edgar Santos da Universidade Federal da Bahia, e Professor do Programa de Pós-Graduação em Ciências da Saúde - UFBA. Tem experiência nas áreas de Imunologia e Dermatologia, com ênfase em Imunologia Celular, Imunoterapia e Ensaios Clínicos. Atua principalmente nos seguintes temas: aspectos clínicos e imunopatológicos da leishmaniose tegumentar americana, hanseníase e reações hansênicas; papel das co-infecções virais na hanseníase; manifestações cutâneas da infecção pelo HTLV-1; novos tratamentos na leishmaniose tegumentar americana.
- Camila Sampaio Ribeiro - Mestrado 2016
- Carvel Suprien - DOUTORADO 2019.1
- Cristianne Andrade da Rocha - Mestrado 2014
- Fernanda Ventin de Oliveira Prates - Mestrado 2014
- Fernanda Ventin Oliveira Prates - Doutorado 2016
- Lídia Maria Medeiros Machado – Mestrado 2012
- Lorena Curvelo Dantas Gondim – Mestrado 2009
- Maria das Graças de Oliveira Brito – Doutorado 2013
- Maria das Graças de Oliveira Brito – Mestrado 2011
- Maria Elisa Alves Rosa - Doutorado 2009
- Marta Regina Machado Mascarenhas - MESTRADO 2020.1
- Mayume Dias Shibuya – Mestrado 2012
- Samir de Figueiredo Azouz - MESTRADO 2019
- Sandra Luiza Tolentino Nolasco - Mestrado 2021.2
- Clinical Presentation and Response to Therapy in Children with Cutaneous Leishmaniasis.
- A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil.
- A pilot and open trial to evaluate topical Bacterial Cellulose bio-curatives in the treatment of cutaneous leishmaniasis caused by L. braziliensis.
- Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
- Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
- Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.
- Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.
- Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum.
- Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome.
- Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.
- Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.
- Clinical criteria for Mucosal Leishmaniasis diagnosis in rural South America: A systematic literature review.
- Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers.
- Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.
- Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.
- Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects.
- Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects.
- Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil.
- Early Cutaneous Leishmaniasis Patients Infected with Leishmania braziliensis Express Increased Inflammatory Responses Following Antimony Therapy.
- Early Suppression of Macrophage Gene Expression by Leishmania braziliensis
- Evaluation of monocyte subsets and markers of activation in leprosy reactions
- Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.
- Exuberant case of verrucous cutaneous leishmaniasis.
- FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis.
- Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis : A Randomized Controlled Trial.
- Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis : A Randomized Controlled Trial.
- High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.
- IL-1β production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis.
- Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium.
- Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
- Mononuclear Phagocyte Activation Is Associated With the Immunopathology of Psoriasis.
- Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis.
- Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.
- Plantar ulcer as an atypical manifestation of cutaneous leishmaniasis.
- Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy.
- Role of Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) in the Early Diagnosis of Amphotericin B-induced Acute Kidney Injury - 2015
- Safety and efficacy of miltefosine monotherapy and pentoxifylline associated with pentavalent antimony in treating mucosal leishmaniasis.
- Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis - 2017
- Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.
- The -308bp TNF gene polymorphism influences tumor necrosis factor expression in leprosy patients in Bahia State, Brazil. Infection, Genetics and Evolution (Print) - 2016
- The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.
- The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis.
- The role of ERBB2 gene polymorphisms in leprosy susceptibility - 2015
- Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B - 2015